Skip to main content
. 1998 Dec;46(6):547–551. doi: 10.1046/j.1365-2125.1998.00835.x

Table 1.

Dosing details (mg day−1) of LTG, CBZ, PHT and VPA for the individual patients included as represented in the three groups: Group 1 = LTG plus VPA; Group 2 = LTG plus VPA plus inducers (CBZ, PHT); Group 3 = LTG plus inducers (CBZ, PHT, etc) without VPA.

graphic file with name bcp0046-0547-t1.jpg